PREMIUM PORK INTERNATIONAL A/S financials
PREMIUM PORK INTERNATIONAL A/S
213800QZQXXYP9R5G538 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €54.9M | €70.5M |
| Cost of sales | €26.5M | €31.8M |
| Gross profit | €15.4M | €24.7M |
| Employee benefits expense | €10.7M | €9.7M |
| Operating profit (EBIT) | -€3.5M | €5.5M |
| Finance costs | €3.5M | €2.7M |
| Profit before tax | -€6.5M | €2.8M |
| Income tax expense | -€907.0K | €482.0K |
| Profit for the year | -€5.6M | €2.4M |
| — attributable to owners | -€5.6M | €2.4M |
| Total comprehensive income | -€3.1M | €2.7M |
| Cash flow statement | ||
| Cash generated from operations | €10.7M | €6.1M |
| Net cash from operating activities | €7.6M | €2.0M |
| Income taxes paid | €544.0K | €1.5M |
| Net cash from investing activities | -€9.2M | -€1.3M |
| Purchase of PP&E (capex) | €6.5M | €5.7M |
| Purchase of intangibles | €3.0K | €44.0K |
| Net cash from financing activities | €743.0K | €266.0K |
| Proceeds from borrowings | €6.7M | €6.0M |
| Repayments of borrowings | €6.0M | €5.7M |
| Net change in cash | -€777.0K | €1.0M |
| Balance sheet | ||
| Total assets | €137.4M | €144.4M |
| Non-current assets | €93.7M | €89.0M |
| Right-of-use assets | €892.0K | €1.4M |
| Current assets | €43.7M | €55.3M |
| Inventories | €5.9M | €9.2M |
| Trade & other receivables | €3.7M | €6.6M |
| Cash & equivalents | €5.5M | €6.4M |
| Total equity | €85.7M | €88.8M |
| Non-current liabilities | €8.4M | €13.4M |
| Lease liabilities (non-current) | €755.0K | €762.0K |
| Current liabilities | €43.2M | €42.2M |
| Derived metrics | ||
| Free cash flow | €1.1M | -€3.6M |
| Operating margin | -6.3% | 7.8% |
| Net margin | -10.1% | 3.4% |
| Return on equity | -6.5% | 2.7% |
| Cash conversion ratio | -1.37× | 0.86× |
| Capex coverage | 1.17× | 0.36× |
| Other reported items | ||
| Adjustments For Decrease Increase In Biological Assets | €4.3M | -€6.0M |
| Adjustments For Decrease Increase In Inventories | €3.3M | -€837.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€73.0K | -€10.2M |
| Adjustments For Depreciation Expense | €7.5M | €7.7M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -€3.6M | -€4.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | -€4.5M | €5.9M |
| Comprehensive Income Attributable To Owners of Parent | -€3.1M | €2.7M |
| Construction In Progress | €1.5M | €3.0M |
| Current Biological Assets | €9.2M | €16.3M |
| Current Prepayments | €442.0K | €586.0K |
| Deferred Tax Assets | €1.6M | €764.0K |
| Depreciation Expense | €7.7M | €7.6M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€52.0K | -€1.0K |
| Equity and Liabilities | €137.4M | €144.4M |
| Finance Costs Paid Classified As Operating Activities | €3.1M | €2.6M |
| Finance Income | €554.0K | €73.0K |
| Finance Income Received Classified As Operating Activities | €554.0K | €73.0K |
| Gains Losses On Fair Value Adjustment Biological Assets | -€3.6M | -€4.0M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €0 | -€23.0K |
| Income Tax Relating To Changes In Revaluation Surplus of Other Comprehensive Income | €556.0K | €138.0K |
| Intangible Assets Other Than Goodwill | €152.0K | €293.0K |
| Issued Capital | €710.0K | €710.0K |
| Land and Buildings | €68.6M | €65.6M |
| Liabilities | €51.7M | €55.6M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €288.0K | €294.0K |
| Noncurrent Biological Assets | €8.1M | €5.6M |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | €1.3M | €1.6M |
| Noncurrent Portion of Noncurrent Loans Received | €4.7M | €9.3M |
| Other Comprehensive Income | €2.5M | €290.0K |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €0 | -€144.0K |
| Other Comprehensive Income Before Tax Gains Losses On Revaluation | €3.3M | €866.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€258.0K | -€317.0K |
| Other Current Liabilities | €1.8M | €5.2M |
| Other Current Receivables | €18.6M | €16.0M |
| Other Noncurrent Assets | €1.6M | €820.0K |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €6.0K | €21.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €698.0K | €487.0K |
| Property Plant and Equipment Including Rightofuse Assets | €83.8M | €82.3M |
| Purchase of Biological Assets | €3.3M | -€3.9M |
| Reserve of Exchange Differences On Translation | €617.0K | €875.0K |
| Retained Earnings | €71.4M | €76.1M |
| Revaluation Surplus | €13.0M | €11.1M |
| Revenue and Operating Income | €55.8M | €72.9M |
| Trade and Other Current Payables To Related Parties | €1.7M | €1.6M |
| Trade and Other Current Payables To Trade Suppliers | €6.8M | €7.2M |
| Undrawn Borrowing Facilities | €70.0K | €4.9M |
Every line item above is a fact tagged in PREMIUM PORK INTERNATIONAL A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.